Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
by Schlenk, Richard Friedrich (Author)
, Weber, D. (Author)
, Krzykalla, J. (Author)
, Kindler, T. (Author)
, Wulf, G. (Author)
, Hertenstein, B. (Author)
, Salih, H. R. (Author)
, Südhoff, T. (Author)
, Krauter, J. (Author)
, Martens, U. (Author)
, Wessendorf, S. (Author)
, Runde, V. (Author)
, Tischler, H. J. (Author)
, Bentz, M. (Author)
, Koller, E. (Author)
, Heuser, M. (Author)
, Thol, F. (Author)
, Benner, Axel (Author)
, Ganser, A. (Author)
, Döhner, K. (Author)
, Döhner, H. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource